Noradrenalin Fresenius Kabi (Noradrenaline Tartrate)

Noradrenaline, the active ingredient in Noradrenalin Fresenius Kabi, is a vasopressor presented as a solution for injection for intravenous use. It treats acute hypotension, septic shock and cardiac arrest in critically ill patients.

GNH USA supplies Noradrenalin Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Noradrenalin is a vasopressor used in critical care to restore blood pressure and support circulation.

Acute hypotension: raises systemic vascular resistance to improve blood pressure. Septic shock: counteracts profound vasodilation to maintain organ perfusion. Cardiac arrest: provides immediate alpha‑adrenergic stimulation to support coronary and cerebral blood flow.

Common Side Effects: - Tachycardia: increased heart rate due to beta‑1 stimulation. - Hypertension: excessive rise in blood pressure from strong vasoconstriction. - Arrhythmia: irregular heart rhythms, especially in patients with underlying cardiac disease. - Headache: secondary to rapid blood pressure changes. - Nausea: gastrointestinal discomfort during infusion. - Peripheral ischemia: reduced blood flow to extremities at high doses.

Serious or Rare Side Effects: - Myocardial ischemia: reduced coronary perfusion leading to chest pain or infarction. - Severe arrhythmias: life‑threatening ventricular tachycardia or fibrillation. - Tissue necrosis: extravasation causing local tissue damage. - Pulmonary edema: fluid accumulation in lungs due to increased afterload. - Cardiac arrest: paradoxical event if dosing is inappropriate. - Severe hypertension: risk of stroke or intracranial hemorrhage.

Noradrenalin requires careful monitoring and dose titration in critical care settings.

Dose titration: adjust infusion rate to achieve target mean arterial pressure. Cardiovascular monitoring: continuous ECG and invasive blood pressure measurement are essential. Extravasation risk: inspect IV site frequently for signs of infiltration. Contraindications: avoid in patients with known hypersensitivity to noradrenaline. Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenalin may interact with several drug classes, requiring vigilance.

Major Interactions (Avoid): - Beta‑blockers: may blunt the pressor response, reducing efficacy. - MAO inhibitors: increase risk of hypertensive crisis. - Tricyclic antidepressants: additive vasoconstrictive effects. - Vasodilators (e.g., nitroglycerin): may diminish pressor action.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance hypotensive effects if noradrenalin dose is reduced. - Diuretics: alter intravascular volume, affecting response. - ACE inhibitors: can potentiate hypotension when combined with low noradrenalin doses.